2025-2031 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

location

Home > Reports >Medical Care > 2025-2031 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research & Trends Analysis Report

2025-2031 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research & Trends Analysis Report

2025-2031 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research & Trends Analysis Report

Publication Date: 2025-10-18
Report Id: 2547613
Industry: Medical Care
Report Page: 108
Chart: 106

PDF Download

Publication Date: 2025-10-18
Report Id: 2547613
Industry: Medical Care
Report Page: 108
Chart: 106

sample

customized

pdf

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Forecast
1.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China ICAD (Intracranial Atherosclerotic Disease) Pathology Share in Global Market, 2020-2031
1.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: China VS Global, 2020-2031
1.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
1.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
1.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
1.5.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
1.5.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Policy

2 Competitive Landscape by Company
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company, 2020-2025
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Concentration Ratio
2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Mergers & Acquisitions, Expansion Plans
2.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Product Type
2.6 Global Geographic Distribution of ICAD (Intracranial Atherosclerotic Disease) Pathology Companies

3 China Competitive Situation by Company
3.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company, 2020-2025
3.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology ICAD (Intracranial Atherosclerotic Disease) Pathology Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Chain
4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Upstream Analysis
4.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Midstream Analysis
4.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream Analysis

5 Sights by Type
5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Classification by Type
5.1.1 Stent
5.1.2 PTA Balloon
5.2 by Type, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031

6 Sights by Application
6.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.1.3 Other
6.2 by Application, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031

7 Sights by Region
7.1 By Region, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
7.3 North America
7.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Market Share
7.4 Europe
7.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Market Share
7.6 South America
7.6.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Market Share
7.7 Middle East & Africa

8 Sights by Country Level
8.1 By Country, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size & CAGR，2020 VS 2024 VS 2031
8.2 By Country, Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.3 United States
8.3.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.3.2 By Company, United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.3.3 by Type, United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.4.2 By Company, Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.4.3 by Type, Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.5.2 By Company, China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.5.3 by Type, China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.6.2 By Company, Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.6.3 by Type, Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.7.2 By Company, South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.7.3 by Type, South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.8.2 By Company, Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.9.2 By Company, India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.9.3 by Type, India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2024 VS 2031

9 Company Profile
9.1 Stryker
9.1.1 Stryker Company Information, Head Office, Market Area, and Industry Position
9.1.2 Stryker Company Profile and Main Business
9.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Models, Specifications, and Application
9.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Gross Margin, 2020-2025
9.1.5 Stryker Recent Developments
9.2 Balt
9.2.1 Balt Company Information, Head Office, Market Area, and Industry Position
9.2.2 Balt Company Profile and Main Business
9.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Models, Specifications, and Application
9.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Gross Margin, 2020-2025
9.2.5 Balt Recent Developments
9.3 TERUMO
9.3.1 TERUMO Company Information, Head Office, Market Area, and Industry Position
9.3.2 TERUMO Company Profile and Main Business
9.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Models, Specifications, and Application
9.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Gross Margin, 2020-2025
9.3.5 TERUMO Recent Developments
9.4 MicroPort
9.4.1 MicroPort Company Information, Head Office, Market Area, and Industry Position
9.4.2 MicroPort Company Profile and Main Business
9.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Models, Specifications, and Application
9.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Gross Margin, 2020-2025
9.4.5 MicroPort Recent Developments
9.5 Acandis
9.5.1 Acandis Company Information, Head Office, Market Area, and Industry Position
9.5.2 Acandis Company Profile and Main Business
9.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Models, Specifications, and Application
9.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Gross Margin, 2020-2025
9.5.5 Acandis Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology should grow from US$ 219 million in 2024 to US$ 380 million by 2031, with a CAGR of 8.3% for the period of 2025-2031.

ICAD (Intracranial Atherosclerotic Disease) pathology is the scientific study of atherosclerotic plaque formation, progression, and the mechanisms by which intracranial arterial disease leads to ischemic brain events. It spans vessel wall changes, inflammation, plaque instability, and thrombosis, linking histopathology to imaging signatures (e.g., high-resolution vessel-wall MRI, CTA, DSA). ICAD pathology underpins clinical diagnosis, endovascular therapeutic design, pharmacologic interventions, and secondary prevention strategies. With the rise of molecular pathology, imaging-omics, and digital pathology, the field is shifting from descriptive characterization toward quantifiable risk stratification and personalized treatment guidance, serving as the integrative hub between basic science, clinical imaging, and medical-device innovation.The average gross profit margin for this product is 70%.

yhen1

ICAD (Intracranial Atherosclerotic Disease) Pathology

user

According to YH Research, the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology should grow from US$ 219 million in 2024 to US$ 380 million by 2031, with a CAGR of 8.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Intracranial atherosclerotic disease is increasingly prioritized in national public-health agendas, prompting systematic upgrades across screening-to-treatment pathways. Industry opportunities arise along three lines: improved diagnostic power through combined imaging-pathology workflows enabling early detection and lesion phenotyping; rising clinical acceptance of endovascular and minimally invasive therapies creating steady demand for dedicated stents, balloons and integrated procedural solutions; and healthcare consolidation that drives hospitals and networks to invest in standardized, traceable ICAD care pathways. These drivers are highlighted in companies’ public disclosures and capital-market materials, creating growth windows for firms that combine technology, brand, and service models.
Despite the attractive outlook, ICAD pathology and related clinical solutions face regulatory, evidentiary, and implementation challenges. Novel diagnostic and interventional products must achieve guideline-level acceptance supported by rigorous clinical trials, which are complex and time-consuming. Lesion heterogeneity across regions and populations complicates universal product applicability and commercial roll-out. Moreover, reimbursement variability and uneven base-level imaging/pathology capabilities limit near-term penetration of high-end imaging and precision-pathology services. Industry players must balance technical robustness with clinical practicality.
Clinical demand is shifting from pure acute revascularization to chronic disease management and risk visualization. Large neurovascular centers favor integrated imaging–pathology–follow-up datasets to support individualized secondary prevention choices. Hospitals and regional networks increasingly prefer standardized imaging reports, automated analytics, and peri-procedural imaging/pathology correlation services. Patient safety, traceability, and quality control are key drivers, favoring imaging+pathology platforms with closed-loop data capabilities and seamless HIS integration.

The upstream ecosystem for ICAD encompasses hardware (high-resolution MRI, CTA/DSA scanners, interventional device materials) and software/reagents (post-processing algorithms, vessel-wall sequences, histology and molecular assay reagents). The capabilities of high-end imaging and precision interventional suppliers set the ceiling for lesion detection and procedural feasibility. Equally critical are the maturity of imaging-sequence optimization, AI-driven image analysis, and digital pathology workflows that convert imaging features into actionable clinical information. Some critical components and advanced imaging modules still depend on global supply chains; public disclosures indicate that strengthening local supply capabilities and strategic partnerships will be vital to secure supply continuity and cost control.

This report aims to provide a comprehensive study of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology. Report Highlights:
(1) Global ICAD (Intracranial Atherosclerotic Disease) Pathology market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global ICAD (Intracranial Atherosclerotic Disease) Pathology market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China ICAD (Intracranial Atherosclerotic Disease) Pathology market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global ICAD (Intracranial Atherosclerotic Disease) Pathology segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global ICAD (Intracranial Atherosclerotic Disease) Pathology segment by Type, and by Application, and regional segment by Type, and by Application.

(6) ICAD (Intracranial Atherosclerotic Disease) Pathology industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Stent
PTA Balloon

Market segment by Application, can be divided into
Hospital
Clinic
Other

Market segment by players, this report covers
Stryker
Balt
TERUMO
MicroPort
Acandis

priceBackground

Purchase Options for Report

Single User License

USD5200.00

Multi Users License

USD7800.00

Corporate Users License

USD10400.00

addToCart

Add to Cart

addToCart

Buy Now

keFu

Quality

Customer

Service

0081-5058402692

global@yhresearch.com

dingZhiBaoGao

Create real business value for our clients

Complete database

Rich expert resources

Accurate data analysis

Professional research team

Customized Reports >>

popular

Popular Reports